
Daniel Pm Wicklund
Examiner (ID: 10795, Phone: (571)270-7508 , Office: P/2833 )
| Most Active Art Unit | 2833 |
| Art Unit(s) | 2833, 2844 |
| Total Applications | 376 |
| Issued Applications | 278 |
| Pending Applications | 0 |
| Abandoned Applications | 98 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16390978
[patent_doc_number] => 20200331919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratio
[patent_app_type] => utility
[patent_app_number] => 16/918772
[patent_app_country] => US
[patent_app_date] => 2020-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16842
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16918772
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/918772 | Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratio | Jun 30, 2020 | Abandoned |
Array
(
[id] => 17850363
[patent_doc_number] => 20220280404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => HAIR COSMETIC
[patent_app_type] => utility
[patent_app_number] => 17/625474
[patent_app_country] => US
[patent_app_date] => 2020-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625474
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/625474 | Hair cosmetic | Jun 30, 2020 | Issued |
Array
(
[id] => 18018934
[patent_doc_number] => 20220370433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => METHOD FOR PRODUCING ACTIVE AGENT ADMINISTERING SYSTEMS BY MEANS OF PAD PRINTING PROCESSES
[patent_app_type] => utility
[patent_app_number] => 17/622531
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4567
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622531
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/622531 | Method for producing active agent administering systems by means of pad printing processes | Jun 25, 2020 | Issued |
Array
(
[id] => 19929716
[patent_doc_number] => 12302906
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-20
[patent_title] => Feed stuff for beneficial organisms that can be used in integrated pest management
[patent_app_type] => utility
[patent_app_number] => 17/631659
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 0
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17631659
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/631659 | Feed stuff for beneficial organisms that can be used in integrated pest management | Jun 25, 2020 | Issued |
Array
(
[id] => 17836439
[patent_doc_number] => 20220273744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => Process and Apparatus for Production of a Granular Cannabinoid Material Essentially Soluble in Aqueous Medium
[patent_app_type] => utility
[patent_app_number] => 17/629867
[patent_app_country] => US
[patent_app_date] => 2020-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5485
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17629867
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/629867 | Process and apparatus for production of a granular cannabinoid material essentially soluble in aqueous medium | Jun 22, 2020 | Issued |
Array
(
[id] => 16581410
[patent_doc_number] => 20210015812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => Methods for Treating Antipsychotic-Induced Weight Gain
[patent_app_type] => utility
[patent_app_number] => 16/899708
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899708
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/899708 | Methods for treating antipsychotic-induced weight gain | Jun 11, 2020 | Issued |
Array
(
[id] => 17161698
[patent_doc_number] => 11147780
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-19
[patent_title] => Multidrug pain management package
[patent_app_type] => utility
[patent_app_number] => 16/899465
[patent_app_country] => US
[patent_app_date] => 2020-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 13281
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899465
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/899465 | Multidrug pain management package | Jun 10, 2020 | Issued |
Array
(
[id] => 17760184
[patent_doc_number] => 20220233796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => METHOD FOR CHARGING A CONTAINER FOR USE WITH A MEDICATION DELIVERY APPARATUS, CONTAINER FOR SUCH AN APPARATUS AND METHOD FOR TREATING A PATIENT
[patent_app_type] => utility
[patent_app_number] => 17/617853
[patent_app_country] => US
[patent_app_date] => 2020-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6444
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617853
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/617853 | METHOD FOR CHARGING A CONTAINER FOR USE WITH A MEDICATION DELIVERY APPARATUS, CONTAINER FOR SUCH AN APPARATUS AND METHOD FOR TREATING A PATIENT | Jun 7, 2020 | Pending |
Array
(
[id] => 17881159
[patent_doc_number] => 20220296636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => Carbon Monoxide as a Treatment for Neurodegenerative Disease
[patent_app_type] => utility
[patent_app_number] => 17/616110
[patent_app_country] => US
[patent_app_date] => 2020-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17616110
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/616110 | Carbon monoxide as a treatment for neurodegenerative disease | Jun 4, 2020 | Issued |
Array
(
[id] => 16839342
[patent_doc_number] => 20210147354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 16/891898
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16891898
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/891898 | IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION | Jun 2, 2020 | Abandoned |
Array
(
[id] => 16877960
[patent_doc_number] => 11028093
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/890663
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42442
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 412
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16890663
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/890663 | 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors | Jun 1, 2020 | Issued |
Array
(
[id] => 16451091
[patent_doc_number] => 20200360517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => NUTRITIONAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/881597
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7121
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16881597
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/881597 | Nutritional composition | May 21, 2020 | Issued |
Array
(
[id] => 16296136
[patent_doc_number] => 20200281859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => ANHYDROUS DASATINIB-CONTAINING PREPARATION
[patent_app_type] => utility
[patent_app_number] => 16/879408
[patent_app_country] => US
[patent_app_date] => 2020-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5986
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16879408
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/879408 | Anhydrous dasatinib-containing preparation | May 19, 2020 | Issued |
Array
(
[id] => 18201238
[patent_doc_number] => 11583611
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Biocompatible phase invertible proteinaceous compositions and methods for making and using the same
[patent_app_type] => utility
[patent_app_number] => 16/878061
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6696
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878061
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/878061 | Biocompatible phase invertible proteinaceous compositions and methods for making and using the same | May 18, 2020 | Issued |
Array
(
[id] => 17799017
[patent_doc_number] => 11413283
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Topical formulations for delivery of hedgehog inhibitor compounds and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/878301
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 23679
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878301
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/878301 | Topical formulations for delivery of hedgehog inhibitor compounds and use thereof | May 18, 2020 | Issued |
Array
(
[id] => 17910422
[patent_doc_number] => 20220312816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => PREPARATION FOR USE IN ENHANCING FORMATION OF SHORT-CHAIN FATTY ACIDS (SCFAS)
[patent_app_type] => utility
[patent_app_number] => 17/612755
[patent_app_country] => US
[patent_app_date] => 2020-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612755
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/612755 | Preparation for use in enhancing formation of short-chain fatty acids (SCFAs) | May 17, 2020 | Issued |
Array
(
[id] => 16282753
[patent_doc_number] => 20200276355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => LARGE 3D POROUS SCAFFOLDS MADE OF ACTIVE HYDROXYAPATITE OBTAINED BY BIOMORPHIC TRANSFORMATION OF NATURAL STRUCTURES AND PROCESS FOR OBTAINING THEM
[patent_app_type] => utility
[patent_app_number] => 16/875543
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12366
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875543
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/875543 | Large 3D porous scaffolds made of active hydroxyapatite obtained by biomorphic transformation of natural structures and process for obtaining them | May 14, 2020 | Issued |
Array
(
[id] => 16282754
[patent_doc_number] => 20200276356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => LARGE 3D POROUS SCAFFOLDS MADE OF ACTIVE HYDROXYAPATITE OBTAINED BY BIOMORPHIC TRANSFORMATION OF NATURAL STRUCTURES AND PROCESS FOR OBTAINING THEM
[patent_app_type] => utility
[patent_app_number] => 16/875554
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875554
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/875554 | Large 3D porous scaffolds made of active hydroxyapatite obtained by biomorphic transformation of natural structures and process for obtaining them | May 14, 2020 | Issued |
Array
(
[id] => 20156922
[patent_doc_number] => 12383520
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-12
[patent_title] => Compound and composition for use in the treatment of premenstrual syndrome and/or premenstrual dysphoric disorder
[patent_app_type] => utility
[patent_app_number] => 17/610366
[patent_app_country] => US
[patent_app_date] => 2020-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610366
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/610366 | Compound and composition for use in the treatment of premenstrual syndrome and/or premenstrual dysphoric disorder | May 11, 2020 | Issued |
Array
(
[id] => 20491523
[patent_doc_number] => 12533378
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-27
[patent_title] => Treatment of adverse effects caused by atypical antipsychotics
[patent_app_type] => utility
[patent_app_number] => 17/995581
[patent_app_country] => US
[patent_app_date] => 2020-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 3197
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995581
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995581 | Treatment of adverse effects caused by atypical antipsychotics | May 9, 2020 | Issued |